Affimed N.V.

Home » Affimed N.V.

Secondary

Affimed N.V.

Affimed engineers targeted immunotherapies, seeking to cure patients by harnessing the power of innate and adaptive immunity.

Symbol

AFMD

Last Closing Price
$2.45

Shares
9,200,000

Effective Date
February 13, 2018

Underwriters
Jefferies, Wells Fargo Securities

To view the prospectus for Affimed N.V., or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253